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LIST OF ABBREVIATIONS 
 
 
• BBG             : Brilliant Blue G. 
• BRVO          : Branch Retinal Vein Occlusion. 
• BSS         : Balanced Saline Solution. 
• CRVO          : Central Retinal Vein Occlusion. 
• ERG          : Electroretinogram. 
• ERMs  : Epiretinal Membranes. 
• ICG                : Indocyanine Green. 
• ILM    :  Internal Limiting Membrane. 
• IMH  : Idiopathic Macular Hole. 
• MP1       : Microperimetry.  
• MVR               :           Microvitreoretinal  Knife. 
• OCT         : Optical Coherence Tomography. 
• PVD  : Posterior Vitreous Detachment. 
• RPE                :           Retinal Pigment Epithelium. 
• VMTS  : Vitreomacular Traction Syndrome. 
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1. I?TRODUCTIO?  
1.1 The eye ball:  
     The human eye is an organ which reacts to light for several purposes. As a conscious 
sense organ, the eye allows vision. Rod and cone cells in the retina allow conscious light 
perception and vision including color differentiation and the perception of depth. The 
human eye can distinguish about 16 million colours. 
[1]
 
1.1.1 The Retina: 
      Anatomically the retina is a delicate thin transparent structure covering the inner 
surface of the posterior part of the eye ball. It is loosely attached to the pigment 
epithelium being closely bound down at the optic disc and at the orra serrata.
[2]
 
1.1.2 Subdivisions of the retina: 
     The retina can be subdivided into 2 regions 
[3]
 
1-Central area measuring 5-6 mm in diameter, concerned with diurnal vision including 
appreciation of colors. 
2-Peripheral large area surrounding it comprising the rest of the retina, concerned with 
summation of weak stimuli as occurs in dim illumination and the perception of 
movements. 
1.1.3 Macula Luta: 
      Anatomically, the macula is defined as an area of the posterior retina containing 
xanthophylls. Clinically, this area is five mm in diameter and its center is located four 
mm temporal and 0.8mm inferior to the center of optic nerve head. It occupies most of 
the area between the vascular arcades.
 [2, 3] 
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1.1.3.1 Subdivisions of the Macula: 
1.1.3.1.1 Fovea Centralis: 
    This is a depression in the inner retinal surface at the center of the macula. Its diameter 
is 1.5 mm as the diameter of an average optic disc head. Clinically, it can be recognized 
with an oval light reflex arising from an increased thickness of the retina and the internal 
limiting membrane.
 [2, 3]
 
1.1.3.1.2 Foveola: 
    It is the central part of the fovea. It measures 0.35 mm in diameter and lies within the 
capillary free zone. It is the thinnest part of the retina and devoid of ganglion cells. Its 
entire thickness consists of only cones and their nuclei. It delivers the most acute visual 
acuity. The umbo is a tiny depression of the center of the foveola.
 [2, 3]
 
1.1.3.1.3 Histology of retina. [2, 3] 
    The retina is formed of ten layers, which are from out to inwards: 
1-Retinal pigment epithelium (RPE). 
2-Layer of rods and cones.  
3-External limiting membrane.  
4-Outer nuclear layer. 
5-Outer plexiform (fiber) layer. 
6-Inner nuclear layer. 
7-Inner plexiform (fiber ) layer. 
8-Ganglion cell layer. 
9-Nerve fiber layer. 
10-Internal limiting membrane (ILM). 
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1.2 Anatomy of the internal limiting membrane:  
    The internal limiting membrane (ILM) is the innermost layer of the retina. It forms a 
boundary between the vitreous and the retina and is a part of the vitreoretinal interface. 
The ILM also acts as  a structural  support  for the  Müller cells  of the retina. 
[4]
 
 
Fig 1. Cross section of normal fovea. (Kanaski J 2003).
 [5]
 
1.2.1 Thickness and continuity: 
      The thickness of the ILM varies from 100-200 nanometers in the anterior retina. 
Posteriorly, the ILM attains a thickness of 0.05-2.0 micrometer. It continues 
uninterrupted at the fovea. It is absent at the edge of the optic disc. 
[6] 
     At the periphery of the retina, the membrane is continuous with the basal lamina of the 
ciliary epithelium. The basal lamina shows breaks at the pars plana and at the ciliary 
processes where vitreous fibrils are in direct contact with the cell membranes of the 
epithelial cells. These breaks in the basal lamina increase with age. The ILM becomes 
thicker and interrupted at the ora  serrata with age. 
[6] 
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1.2.2 Structure: 
     Both the retina and the vitreous contribute to the formation of the ILM and 
vitreoretinal interface. 
[5] 
    The vitreous portion of the ILM appears smooth in flat sections of the retina, except at 
the retinal periphery where it may be irregular. 
[7] 
 
1.3 Anatomy of the vitreous:  
        The vitreous body fills the eyeball behind the lens. It thus occupies about four-fifth 
of the eyeball and lies between the lens and the retina.
 [7, 8]
 
The vitreous body is firmly attached to the retina in some regions: vitreous base, 
margin of the optic disc, margin of the macula and overlying retinal vessels.           
Elsewhere, the attachment between the retina and the vitreous is loose. 
[9, 10] 
The function of the vitreous is transmission of light and contributes slightly to the 
dioptric power of the eye. It supports the posterior surface of the lens and possibly assists 
in holding the neural part of the retina against the pigmented part. The vitreous probably 
plays an important role in retinal metabolism by serving as a repository for chemical 
substances and influencing the movements of solutes and solvents. Although, the absence 
of vitreous (after a surgical procedure, called vitrectomy) does not affect the retinal 
function.  
[2, 10]
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1.4 Macular holes 
Full thickness macular holes are defined as defects involving all layers of the retina, 
from the internal limiting membrane through the outer segment of the retinal 
photoreceptors in the foveal area. Lamellar macular holes involve only a portion of 
retinal layers. 
[11] 
The most common cause of full thickness macular hole is the idiopathic macular 
hole. Other causes include traumatic macular hole, pathological myopia, solar 
retinopathy, vitreomacular traction syndrome, traction from epiretinal membranes and 
degenerative conditions of the retina. 
[12, 13, 14] 
1.4.1 Idiopathic macular hole (IMH): 
Gass in 1988 proposed that tangential traction caused by shrinkage of premacular 
vitreous cortex is responsible for idiopathic macular hole formation. The process 
typically begins in eyes with liquefied pockets of premacular vitreous and no posterior 
vitreous detachment (PVD). This suggests that (IMH) begins as foveal cystic changes 
with unroofing  of the hole. Scanning electron microscopic studies have shown that even 
after  apparent spontaneous PVD, there are remnants of posterior vitreous membrane in 
the foveal area. These glial cells can create tangential traction leading to formation of 
idiopathic macular hole.
[13]
 
  Clinical stages of macular hole formation: 
Gass described a series of chronological stages of fundus changes in the majority of 
cases of idiopathic macular holes.
[13] 
These clinical stages originally were described in a 
retrospective series. 
[15, 16]
 
Stage (1a):  A yellow spot 100-200 µ in diameter is centered on the Foveola. This stage 
is not pathognomonic of idiopathic macular hole formation. It is caused by localized 
shrinkage of perifoveal vitreous cortex and is also seen in cases of: 
  *Central serous chorioretinopathy 
  *Aphakic cystoid macular edema 
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  *Solar retinopathy  
Associated loss or reduction in the fovea depression occurs. This lesion may be the 
same as that described by others as cyst. 
[17, 18]
 
 
 
Fig 2. Stage 1 A impending macular hole. (Kanaski J 2003).
 [5]  
Stage (1b): A yellow ring 200-300 µ in diameter and also is centered on the foveola, this 
finding appears to be specific to macular hole formation, patients of this stage are often 
asymptomatic, with a diminution of visual acuity with metamorphopsia caused by further 
vitreous contraction leading to tiny breaks in the photoreceptors in the center of the 
foveola but with intact ILM. 
 
Fig 3. Stage 1 B occult macular hole (Kanaski J 2003).
 [5]
 
Fate of stage 1 macular hole: Stage 1 lesions are transient, they resolve within few 
weeks owing to spontaneous vitreofoveal separation. Resolution may be accompanied by 
improvement of vision and metamorphopsia. A semitranslucent premacular opacity may 
be visible biomicroscopically representing contracted vitreous cortex  
Stage (2): Caused by condensation of perifoveal cortical vitreous with separation from 
the retinal surface to form pseudo-operculum. It is the first evidence of full thickness 
retinal defect. This change usually occurs at the inner edge of the yellow ring. 
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Fig 4. Stage 2 Macular hole (Kanaski J 2003).
 [5]
  
 
Fate of stage 2 macular hole: The macular hole enlarges over a period of days to weeks 
to stage 3 or 4. Eyes with eccentric holes and those with pericentral hyperfluorescence 
are more likely to progress than those with centric holes. 
Stage (3): It is defined as a fully developed macular hole of 400 um or more in diameter 
with vitreofoveal separation. In 75% of cases an opacity can be detected on the detached 
posterior vitreous face and anterior to the macular hole. This opacity was initially thought 
to be an operculum.  
The underlying retinal hole continues to enlarge, presumably because of centrifugal 
retraction of retinal tissue. The underlying retinal pigment epithelium (RPE) within the 
area of retinal hole formation shows thinning and depigmentation. This contributes to 
hyperfluorescence seen on the fluorescein angiography. 
 
Fig 5. Stage 3 macular hole (Kanaski J 2003).
 [5]
 
Stage (4): It is defined as full thickness macular hole with complete posterior vitreous 
detachment with the presence of Weiss ring infront of the optic nerve head.  
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Fate of stage 3 and 4 macular hole: Visual acuity stabilizes at about 0.1. Spontaneous 
closure is rare but may be caused by growth  of an  epiretinal  membrane. 
[19]
 
 
Fig 6. Stage 4 macular hole (Kanaski J 2003).
 [5] 
 
1.4.2 Traumatic macular hole: 
Initially trauma was believed to be the  major  cause  of  macular  hole formation.
 
[20]
 The exact mechanism of formation of macular hole after blunt trauma is uncertain.
 
[21]
Yanagiya et al., theorized that the forces of impact transmitted to the macula caused 
foveal rupture and they supported their theory by the elliptical or irregular appearance of 
the edges of the macular hole. 
[22]
 Others theorized that countercoup forces led to sudden 
vitreal separation and traction on the macula with hole formation. 
[23]
 Another theory 
suggested that trauma causes rupture of a previously developed macular cyst with 
subsequent hole formation. 
[22, 23, 24]
 
Johnson et al.,
 [21]
   proposed the following mechanism: blunt trauma leads to 
indentation of the cornea followed by outward expansion of the globe at the equator and 
flattening of the posterior pole followed by posterior displacement of the posterior pole.  
Sudden flattening, then posterior displacement of the posterior pole exerts sudden 
traction on the anatomically thin fovea resulting in immediate hole formation. This 
traction was described as tangential and the vitreous has a role in its development. 
[24]
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1.4.3 Myopic foveoschisis and myopic macular hole: 
       Myopic foveoschisis is the splitting of retinal layers in the macula and can result in 
metamorphopsia, blurring of vision and predisposes to myopic macular holes. Myopic 
foveoschisis and macular holes causing retinal detachments are more common with high 
myopia.
 [25, 26, 27]
 Since the fovea and to a lesser extent the macula are dependent upon 
the blood supply of these deeper layers, a relative ischemia can exist in the sensory retina. 
Furthermore, staphyloma formation with accentuated stretching of the posterior pole 
causes thinning of the retina with distinct flattening of the macular area probably because 
of thinning of the ganglion cells layer. Cystic degeneration, schisis formation then 
atrophy of the macula may ensue with the possibility of macular hole formation. 
[28]
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1.5 Macular pucker 
Macular pucker has also been called cellophane maculopathy, epiretinal membranes 
and premacular fibrosis. In adults, these lesions have been described as an idiopathic 
occurrence as well as secondary to intraocular inflammation, macular holes, trauma, 
retinal detachment, retinal vascular disease and interestingly diabetes without evidence of 
retinopathy.  
[29]
 
1.5.1 Histopathology: 
In 1981, Kampik using transmission electron microscope defined five basic cell 
types present in epiretinal membranes: retinal pigment epithelial cells, macrophages, 
fibrocytes, fibrous astrocytes, and myofibroblast-like cells. The RPE cells were only 
noted in association with retinal detachment. 
[30]
 
A posterior vitreous detachment, commonly associated with idiopathic epiretinal 
membranes, may precipitate the formation of these membranes by causing defects in the 
ILM. 
[31]
 It is presumed that glial cells, which have direct access to the internal surface of 
the retina through breaks in the ILM, may proliferate or undergo transformation into 
other cell types, forming epiretinal membranes.
 [31]
  A new theory discusses the role of a 
pathologic posterior vitreous detachment in which parts of the vitreous cortex  remains 
attached to  the retinal surface. Cells within  this  collagenous layer may proliferate and  
finally  contribute to tractional  forces at the retinal surface.
 [32]
 Epiretinal membranes 
may contain myofibrocytes which may exhibit their contractile properties in the clinical 
feature of prominent retinal striae especially in younger patients. 
[33]
 
Increased numbers of fibrous cells and collagen may correlate with thicker and 
whiter membranes, which are more found in young patients. 
[34] 
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1.5.2 Idiopathic epimacular membranes: 
The incidence of idiopathic membranes increases with age. Idiopathic membranes 
are very rare in children and adolescents. 
[35]
 Metamorphopsia, distortion of amsler grid 
pattern and reduction of the visual acuity occur once the fovea is involved. As retinal 
traction develops, the small vessels within the temporal vascular arcades may become 
tortuous. The large retinal vessels are usually normal early in the disease process, but 
with progression they may become darker, dilated and tortuous. The disease process may 
advances rapidly over few months but more commonly progresses slowly over long 
periods of time.  
[36]
 
1.5.3 Secondary epimacular membranes: 
Secondary epimacular membranes may occur in patients who have undergone 
previous retinal surgery. Several preoperative and intraoperative factors have been 
associated with increased incidence of epimacular membrane formation after retinal 
reattachment surgery. These factors include increased patient age, vitreous hemorrhage 
and drainage of subretinal fluid. 
[37]
 
1.5.4 Clinical stages of epiretinal membranes: 
In 1987 Gass offered the following classification:
 [36]
 
Grade 0: Translucent membranes unassociated with retinal distortion (cellophane 
maculopathy). 
Grade 1: Membranes causing irregular wrinkling of the inner retina (Crinkled cellophane 
maculopathy). 
Grade 2: Opaque membranes obscuring the underlying vessels with prominent retinal 
distortion. 
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1.6 Vitreomacular traction syndrome 
The hallmark of a vitreomacular traction syndrome is a persistent attachment of the 
vitreous to the macula in eyes with an incomplete posterior vitreous detachment. The 
most common morphological configuration is a vitreous separation peripheral to a zone 
where the cortical vitreous remains attached to the retina at the macula and the optic 
nerve head. Traction on the macula causes decreased vision, metamorphopsia, 
photophobia and micropsia.
[38]
 
There are remarkable variations concerning the vitreoretinal morphology in eyes 
with vitreomacular traction syndrome. This syndrome comprises a broad spectrum of 
frequently unrecognized clinical findings, ranging from peripheral vitreous separation 
with residual foveal attachment to multiple areas of tractional retinal detachment caused 
by persistent, focal posterior and peripheral vitreous attachment.
 [39, 40, 41]
 
Based on the relationship of the posterior vitreous cortex to the retina in cases of 
epimacular membranes and according to its clinical effect, Akiba in 1991 classified this 
relationship into four groups. 
[42]
 
Group 1: No posterior vitreous detachment.  
Group 2: Partial posterior vitreous detachment but no vitreoretinal adhesion or traction to 
the area of the preretinal macular fibrosis. 
Group 3: Partial posterior vitreous detachment with vitreous traction to the area of the 
preretinal macular fibrosis. 
Group 4: Complete posterior vitreous detachment. 
1.6.1 Histopathology: 
Vitreomacular traction membranes revealed fibrocellular membranes composed of 
fibrous astrocytes, fibrocytes, myofibroblasts, collagen and fragments of the internal 
limiting membrane.
 [43] 
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1.7 Indications for surgical ILM peeling 
1.7.1 ILM peeling in macular pucker and in vitreomacular traction: 
Peeling of ILM has been indicated in cases of epimacular proliferation. Removal of 
epimacular proliferation/ILM may help for complete tractional release with high 
anatomical and functional success rate. 
[44, 45] 
1.7.2 ILM peeling in macular hole: 
In cases of idiopathic macular hole, ILM peeling was found to be effective not only 
in hole closure but also in visual recovery. ILM peeling was suggested to improve visual 
and anatomic success in all stages of macular holes. 
[46, 47] 
The ILM peeling is intended to remove cellular proliferation on the ILM in IMH 
and to release tractional forces generated by contraction of these cells and almost remove 
the scaffold for the proliferation of glial cells. 
[48]
 
Another indication for ILM peeling is the myopic macular hole with retinal 
detachment. In such cases, removal of ILM can result in a high initial success rate of 
retinal reattachment. 
[49]   
1.7.3 Other indications for ILM peeling: 
Recent studies and reports have described the effectiveness of ILM removal in 
pseudo-hole cases in myopic eyes,
 [50] 
vein occlusive diseases such as central retinal vein 
occlusion (CRVO) or branch retinal vein occlusion (BRVO).
 [51] 
It has been 
recommended that ILM peeling be performed after silicone oil removal to prevent late 
postoperative complications such as secondary macular pucker.
 [52]   
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1.8 Techniques of ILM peeling 
Several techniques have been described to achieve this surgical step of ILM peeling 
during vitreous surgery. Neither of these techniques have proved to be exclusively the 
best nor the easiest nor the safest among others. The technique is still left to the surgeon’s 
preference and skills. 
1.8.1 The first technique: 
It was described by Rice in 1999. 
[53] After complete vitrectomy and removal of the 
posterior hyaloid, ERMs are excised as much as possible. The ILM is then punctured 
with a sharp tipped Eagle dissecting needle or a bent tipped MVR (70-90°). The needle is 
tilted slightly downwards 15-20° to engage the ILM. Tano’s diamond dusted membrane 
scraper is then introduced with the tip directed tangentially into the opening of the ILM 
and beneath it. The scraper is then advanced slowly in an effort to engage the ILM and 
not the nerve fiber layer. If a translucent or even subtle white membrane is seen over the 
instrument, the latter is in the nerve fiber layer and hence too deep. The instrument is 
drawn back and readvanced in the proper plane. If this is not possible, another site is 
picked and punctured with the needle or microvitreoretinal  knife (MVR). 
Sometimes the ILM may be seen over the elevator as clear cellophane like sheet 
and sometimes nothing is seen, in this case advancing or lifting the instrument will cause 
movement of the underlying retina or retinal striae. 
Once the ILM elevator is in proper plane it is advanced slowly in a straight line 
towards a point approximately 3 mm to the left of the macular hole in the horizontal 
meridian, and at that point the instrument is directed more vertically. 
Once a sheet of the ILM is elevated the instrument is withdrawn and the ILM is 
grasped by an endgripping forceps that prevents shredding of the grasped ILM and then it 
is peeled off like the anterior lens capsule in capsulorrhexis. Sometimes the ILM is firmly 
adherent, that is why care must be taken to keep the traction force horizontal (tangential 
to retina). Every effort should be made to peel off the ILM in one piece and not to shred 
it. 
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1.8.2 The second technique: 
This technique differs from the first one that it does not involve the use of the ILM 
elevator. The surgeon starts by making a small opening and a flap tear in the ILM by a 
bent tipped MVR. Then, the endgripping forceps is introduced to grasp the flap and to 
proceed with peeling directly without creating a plane between the ILM and nerve fibre 
layer. It can be done in a continuous circular motion. Some surgeons do not remove the 
ERMs and leave them to be removed with ILM in a single step to minimize manipulation 
during surgery. 
[46] 
1.8.3 The Third technique: 
This describes a fluidic dissection of the ILM. It is considered by some to be a less 
traumatic way of removing the ILM in all forms of traction maculopathy. It consists of a 
viscoelastic syringe and tubing that connect to a viscous injector. There is a 20 gauge 
hand piece that supports the smallest cannulated needle. The needle is rectangular in 
shape with a short bevel sharpened on the bottom surface. This shape creates a tiny 
dissecting surface that is parallel to the retina and allows easy cannulation of the sub-ILM 
space. Using the injector at a low pressure, a small elevation of the ILM is created. Once 
the sub-ILM space is cannulated, the needle is slowly advanced while the pressure is 
increased. This allows for smooth and rapid dissection of the ILM with the overlying 
proliferation. After the ILM is elevated, it can be removed with ILM forceps without 
touching the retina.
 [54] 
The technique used in this series of cases according to 2nd techniques is less 
traumatic. 
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1.8.4 Staining techniques of the ILM: 
The peeling of the internal limiting membrane and epiretinal membrane is a 
challenging maneuver in vitreoretinal surgery. Some of the technical difficulties usually 
encountered   during ILM peel surgery are incising or grasping the ILM surface; finding 
the edge of the initial incision on the ILM creating a flap; and may be most importantly, 
identifying the areas where the ILM has already been peeled. Epiretinal membranes may 
be difficult to visualize if fibrosis or pigment deposition is absent, and as a result, the 
removal of the membrane may be incomplete. Inadvertent trauma to the retina may also 
occur, in particular during ILM peeling.
 [55] 
1.8.4.1 Indocyanine Green Dye (ICG): 
ICG is a hydrophilic dye used for angiography because of its properties as a 
fluorophore. Indocyanine green also acts as a chromophore staining the ILM green 
because of its affinity to laminin and collagen type IV within the ILM. 
[56]
 It is the most 
potent and specific ILM stain used in macular hole surgery. 
[57]
 The most commonly 
reported adverse events after ICG –assisted ILM peeling are visual field defects. 
[58-66]
 
Several mechanisms related to ICG induced ocular toxicity include: 
1- A direct dose  dependent  biochemical  injury  to  RPE  cells  and  ganglion cells.
[67-
68-69]
 
2- Osmolarity effect of the ICG–solution at the vireo-macular interface, indicating that 
hypotonic ICG solutions could be harmful all to the RPE. 
[70]
 
3- Phototoxic properties  of the ICG inducing photo-oxidative cell damage caused by an 
overlap in absorption spectra between ICG peak (780-830 nm)  and different types of 
endoillumination  used in vitreoretinal surgery. 
[71-72] 
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1.8.4.2 Trypan Blue: 
Trypan blue is a vital stain used in surgery for removal of epiretinal membranes and 
to stain the anterior lens capsule during cataract surgery. Trypan blue also stains cells 
with damaged cell membranes in a dose dependent matter.  
[73-74] 
The faint bluish staining seen after trypan blue exposure is probably because of the 
affinity to cellular proliferations on the internal limiting membrane rather than to the 
acellular internal limiting membranes.
 [75] 
Trypan blue staining is unlikely to have toxic side-effects when used in low and 
clinically relevant concentrations. 
[76] 
1.8.4.3 Brilliant Blue G (BBG): 
Brilliant blue is a blue biostain also known as acid blue 90 and coomassie brilliant 
blue G, that provides selective staining of the ILM. The dye is relatively new (approved 
in Europe in 2006).
 [77]
 
         Enaida et al., 2006 examined the effect of brilliant blue G (BBG) stain on rats. After 
intravitreal BBG, no toxic effects of BBG, such as corneal edema, severe retinal edema 
or endophthalmities were observed by surgical microscopy over a period of 2 months.  
Normal structure of the retina was preserved in eyes injected with high doses of BBG 
(10mg/ml) with no infiltration of inflammatory cells observed. Regarding the 
electroretinogram (ERG), which was done to evaluate the retinal function, no remarkable 
reduction in ERG amplitudes, were observed.
 [78] 
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1.9 Evaluation of the function of the macular area 
     For many years, ophthalmologists have been using standard visual acuity testing to 
evaluate the function of the macular area.  Recent advances in medical and surgical 
options of macular diseases have changed treatment modalities and therefore improved 
the prognosis of macular diseases. Therefore, more exact evaluation and documentation 
of macular function has become essential.
 [79]
 
1.9.2 Microperimetry (MP1): 
      The Micro Perimeter (MP1, Nidek instrument Inc., Padova, Italy) is not a scanning 
laser ophthalmoscope. Rather, the fundus image is observed using an infrared fundus 
camera with 45° field of view. 
       Microperimetry is a recent tool to evaluate the function of the macula in detail. The 
first Microperimetry was performed via a scanning laser ophthalmoscope. This device 
was not used for this study.  
Perimetry using the MP1 is performed with a liquid crystal display controlled by a 
special software. The major advantage compared to the scanning laser ophthalmoscope is 
the automatic eye tracking, which allows real-time compensation for eye movements and 
therefore presentation of any stimulus exactly at the predefined retinal location. During 
stimulus presentation, the eye tracker monitors the eye position with the frequency of 
25Hz i.e. each 40 ms. If the reference area has moved due to eye movement and can be 
found, the stimulus will be replaced accordingly. If the reference area can not be found, 
the stimulus will  turned off. 
[79]
   
In the mean time, a color fundus photograph can be acquired by the MP1 following 
testing, and the result of the examination can be registered either automatically or 
manually with the infrared image. 
The current MP1 software enables the examiner to choose between a symbolic, a 
numeric or an interpolated presentation of the resulting differential light thresholds.  
The diameters of the stimuli can be altered between sizes comparable to 
conventional goldmann-perimeter size I and V. Differential light threshold is measured 
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with 4-2-1 staircase strategy in which stimulus intensity is  increased or decreased (Fig 7, 
8)  in 4 dB step until threshold is crossed; intensity is then reduced in 2 dB step until  a 
second cross over is made. The final threshold is set 1 dB between the last 2 
presentations.  The 4-2 staircase strategy is adopted only when single cross over of 
threshold is obtained. The resulting time saving is 30% to 50% at randomly selected 
stimulus locations. Starting luminance for the first four stimuli locations is 2 dB higher 
than the normal threshold to reduce examination time.
 [79]
 The maximum light sensitivity 
is 20 dB according to the maximum differential light threshold of normal person. 
[79]
  
 
 
Fig 7. 4-2-1 and 4-2 Strategy with initial stimulus under 
threshold (Microperimeter MP1 Operator’s Manual 2007)
 [80]
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   Using the MP1 stability and location of fixation can be tested as an isolated test prior to 
and or after the perimetric procedure to gain information of the patients compliance. It 
has to be kept in mind that the accuracy of the initial stored fundus photograph is of 
major importance when judging the exact location of fixation. 
[79]
  
 
1.10 Purpose of the study 
The purpose of this study is to evaluate the anatomical and functional outcome of 
vitreoretinal microsurgery with internal limiting membrane (ILM) peeling. The influence 
of the additional use of brilliant blue G staining, of the ILM during surgery should also be 
examined in eyes suffering from macular hole, macular pucker or vitreomacular traction. 
 
Fig 8. 4-2-1 and 4-2 Strategy with initial stimulus over 
threshold (Microperimeter MP1 Operator’s Manual 2007)
 [80]
 
  
25 
2. PATIE?TS A?D METHODS 
              The study was conducted as an observational, non randomized prospective 
study of forty-eight patients who underwent vitreomacular surgery with internal limiting 
membrane peeling. Treatment indications were idiopathic macular hole, macular pucker 
and vitreomacular traction syndrome. The study was carried out at Ludwig-Maximilians 
University- Eye hospital-Munich, Germany from April 2009 to March 2010.  The use of 
the staining agent BBG during vitreous surgery was at the discretion of the surgeon 
during the procedure. 
Patients were classified into 2 groups: 
A- Sixteen patients suffering from idiopathic macular hole, were treated by internal 
limiting membrane (ILM) peeling following 23g pars plana sutureless vitrectomy. This 
group was further subdivided into: 
1A-  Fourteen eyes that underwent ILM peeling assisted by BBG staining. 
2A-  Two eyes that underwent ILM peeling without assisted staining. 
B- Twenty-four patients suffering from primary macular pucker or vitreomacular 
traction syndrome, were treated by internal limiting membrane (ILM) peeling following 
23g pars plana sutureless vitrectomy. This group was further subdivided into: 
. Seventeen eyes that underwent ILM peeling assisted by BBG staining-B1     
.   Seven eyes that underwent ILM peeling without assisted staining -B2      
2.1 Preoperative examinations: 
 2.1.1 Assessment of the best corrected visual acuity and refraction: 
The refraction was measured using a Rodenstock autorefractometer; the best-corrected 
visual acuity testing was done using decimal chart. 
2.1.2 Slit lamp examination: 
This was performed to assess the condition of the cornea, the crystalline lens, the pupil, 
the iris and to measure the intraocular pressure by applanation tonometry. Further, indirect 
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ophthalmoscopy was used under dilated pupil condition (1% tropicamide). The fundus was 
examined to detect retinal detachment, peripheral breaks or holes, the state of the posterior 
hyaloid, the condition of the vitreous and the choroid. 
2.1.3 Fundus photography: 
        Photographs of the macular area were taken using Zeiss fundus camera with red free 
light. 
2.1.4 Fundus autofluorescence, fluorescein angiography, infrared images and spectralis 
OCT (Heidelberg HRA+OCT): 
This was done to assess macular thickness, edema, macular pucker, vitreomacular 
traction and macular hole. 
2.1.5 Microperimetry (MP1): 
Fundus–monitored Microperimetry was performed through normal pupil in a dark room 
using MP1 (Nidek Instruments Inc., Padova, Italy). The MP1 software contains an automatic 
tracking system for fundus movements; this evaluates every acquired frame for shifts in the x 
and y direction of the fundus with respect to a reference frame obtained by an infrared 
camera at the beginning of the examination. 
The patient was informed to press on a special button connected to the microperimeter 
as soon as the patient can see a light stimulus. If the patient can see the weakest stimulus 
(20dB) this means highest macular sensitivity. 
A 4-2-1 staircase strategy with Goldmann III stimulus was used and 40 stimulus 
locations covering the center 10° were examined. The white background illumination was set 
at 1.27 cd/m
2
. The differential luminance, defined as the difference between stimulus 
luminance and background luminance, was 127 cd/m
2
 at 0 dB stimulation and the maximum 
stimulus attenuation was 20 dB. The duration of the stimulus was 200 milliseconds and the 
fixation target was varied in size according to the patient’s visual acuity. There were eight 
location spots covering the central 2° field, 24 location spots covering the central 6 ° field, 
and 40 location spots covering the entire central 10° field. After fundus Microperimetry a 
colored fundus image was taken, registered within the Microperimetry. 
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2.2 Exclusion criteria: 
Eyes with hereditary retinal diseases, after laser photocoagulation, pathological 
myopia, inflammatory choroidopathies, retinal detachment, dense vitreous hemorrhages, 
diabetic retinopathy, age related macular degenerations, ocular trauma or past 
vitreoretinal surgeries and patients with lens opacity grades 3, 4 and 5 were excluded 
from the study. 
2.3 Operative techniques: 
2.3.1 -Anesthesia: 
     -Local retro-bulbar anesthesia was used in 35 patients, general anesthesia in five 
patients.  
2.3.2 -Surgical procedure: 
Combined cataract surgery and sutureless trans-conjunctival 23g pars plana 
vitrectomy were performed in 19 cases and sutureless pars plana vitrectomy only in 21 
cases. 
 The surgical procedures were done by four vitreoretinal surgeons at the Eye 
hospital of Ludwig-Maximilians University. 
2.3.2.1-Catarct surgery: Using micro incision cataract surgery. 
[81]
 
      Corneal incision was created, 2.00 mm diameter in size in the upper part, first 
horizontally, followed vertically to create a valve like opening. Additional 2 side ports 
were made using superblade 15° at 2 and 10 o’clock. Afterwards injection of a 
viscoelastic material into the anterior chamber was performed using healon. This was 
used to stabilize the anterior chamber and to protect the corneal endothelium. In the next 
step, needle capsulorhexis was performed by using a cystotome that was created from a 
27 g bended needle. The anterior capsule was perforated at the center of the crystalline 
lens; the needle was pulled towards the periphery, tearing the anterior capsule for a length 
equivalent to 2/3 the radius of the rhexis as desired. A flap of the capsule was raised and 
progressively pulled in an anti-clockwise direction to produce a continuous circular 
opening of the anterior capsule. Hydrodissection was performed by injection of a small 
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amount of a balanced saline solution (BSS) under the capsule until a wave was observed 
in the pupillary field, propagated to the opposite side between the posterior capsule and 
the cortex. Hydro-delineation was done by injecting fluid into the nucleus, to help to 
separate the nucleus from the cortex and epinucleus and to protect the posterior capsule 
during phacoemulsification. Thereafter, phacoemulsification was done using varying 
phacovitrectomy machines (Geuder, Oertli or Alcon). Different techniques were used to 
emulsify the nucleus, for examples ‘Divide and Conquer’, ‘Phaco-Chop’, ‘Stop and 
Chop‘ and ‘Quick and Chop‘ according to the lens status. Finishing Phacoemulsification 
a switch to bimanual system was done for infusion-aspiration of cortical fragments and to 
clean the capsular bag from any lens fibers. 
       After cleaning the capsular bag, again, a viscoelastic material was injected into the 
anterior chamber (Healon). The wound bed was widened another 0.5 mm to implant an 
acrylic lens into the capsular bag. The viscoelastic material was aspirated and hydration 
of the wound bed was then done to close the self sealing wound. 
[77]
 
2.3.2.2 -Pars plana vitrectomy: was performed using 23-gauge sutureless pars plana 
vitrectomy technique.
[82]
 After insertion of 3 trocars a core vitrectomy was done and the 
posterior hyaloid was detached using a cut rate of 3000 Cuts/Min. Peripheral vitreous was 
removed to relief any potential peripheral traction and to detect any potential peripheral 
breaks.
 
 
      After central vitrectomy, a disposable macular contact lens was applied to the cornea 
to get good viewing of the macular area. Epimacular membrane and ILM peeling were 
done either with or without assisted staining of the ILM. 
       An Eckard ILM forceps was applied near the vascular arcades to grasp the ILM, and 
to peel the ILM within the vascular arcades and over the foveola. In cases of BBG 
staining of the ILM after vitrectomy, BBG solution (Brilliant peel, sterile 1 ml ampule, 
containing 0.25 mg brilliant blue G - Fluoron, Neu-Ulm, Germany) was injected into the 
vitreous to cover the retina. After a few seconds, the vitreous chamber was washed with 
BSS and the ILM stained blue. ILM peeling was performed as mentioned above. 
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        At the end of the surgery, the vitreous cavity was filled with air, the saline was 
removed via a float needle. In cases of macular hole 15% C2F6 gas was injected through 
the infusion canula to achieve a prolonged tamponading of the macular hole. In macular 
pucker cases, no fluid air exchange was done and the operation was ended with saline 
tamponading. 
 
2.4 Postoperative management:  
       Face down positioning was achieved for all patients after the use of C2F6 15% gas. 
The others had no special position. Patients were examined daily for 5 days to assess the 
condition of anterior segment, intra-ocular pressure (IOP) and retinal attachment. 
Postoperative medication included combination of antibiotic and corticosteroid eye 
drops 4 times per day for up to one month with gradual tapering, depending on the 
condition of the eye.  
All the preoperative examinations mentioned before were repeated again at the 
postoperative follow up (mean 93.875 days). 
2.5 Statistics: 
Statistics were carried out using Microsoft Excel spreadsheet (Microsoft 
Corporation, Redmond, WA, USA) and analyzed using SPSS 17.0 for windows (SPSS 
Inc.,Chicago, IL USA). The Wilcoxon signed-rank test was used .On all tests p <0.05 
was considered significant. 
 2.6 Ethical issues: 
The study was performed in accordance to the ethical standards laid down in the 
1964 declaration of Helsinki and Institutional Review Board approval was obtained. 
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3. RESULTS  
 
Forty patients were enrolled in the study, 22 males and 18 females. The average age of all 
patients was 67.6 years (range 56-79). The average follow up time was 93.875 days (range 86-
101) (Table 1). All cases in the postoperative follow up were pseudophakic. The following 
results represent the findings of the last examinations of the obtained follow-up. 
 
 
 Table 1: Age of patients and follow up period. 
 Age  
[years] 
 
Follow up 
[days] 
 
Number of eyes 
Mean 
Standard deviation 
Minimum 
Maximum 
40 
67.6 
± 6.819 
56 
79 
40 
93.875 
± 4.88 
86 
101 
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3.1- Idiopathic macular hole (group A) 
Sixteen eyes with idiopathic macular holes (grade 2 to 4) were included. Fourteen eyes 
underwent pars plana vitrectomy and peeling of ILM with assisted (BBG) staining and 2 eyes 
underwent peeling of ILM without using assisted staining (Table 2). All cases of macular 
hole achieved successful closure of the hole after the first surgery.  
Table 2: ILM peeling of eyes with macular hole.  
Number of eyes Frequency Percent 
Without staining 
With ( BBG) staining 
Total number 
2 
14 
16 
12.5% 
87.5% 
100% 
 
 
3.1.1 Eyes that underwent ILM peeling using BBG assisted staining (A1). 
Measurements of the mean visual acuity in eyes that underwent peeling of ILM with 
assisted BBG staining tested by decimal chart revealed postoperative improvement of two or 
more lines in 13 eyes and deteriorated in one eye.   This improvement was statistically 
significant (p=0.019) (Table 3). 
 
 
Table 3. Comparison between mean preoperative versus postoperative visual acuity in 
eyes that underwent ILM peeling with assisted BBG staining.  
 
Number of eyes   Mean visual acuity 
preoperative 
Mean visual acuity 
postoperative  
P value 
14 0.2 0.50 0.019* 
* Statistically significant 
 
 
 
 
Using microperimetry in eyes with macular hole that underwent peeling of ILM 
with BBG assisted staining, revealed  a significant postoperative improvement of the 
mean macular sensitivity from 11.43 dB preoperative to 14.32 dB postoperative 
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(improved in 12 eyes out of 14). This improvement was statistically significant 
(p=0.0228) (Table 4, 5). 
The mean macular defect improved as well from -4.20 dB preoperative to -2.70 dB 
postoperative (improvement in 12 eyes out of 14). This improvement was also 
statistically significant (p=0.0366) (Table 4, 5). 
 Measurements of the mean fixation spot revealed change from 65.06% 
preoperative to 66.78% postoperative. However, this change was statistically not 
significant (p=0.851) (Table 4, 5). 
  
Table 4. Microperimetry relations between the mean preoperative versus postoperative 
macular sensitivity, mean macular defect and fixation spot in eyes that underwent 
peeling with assisted BBG staining. 
 
 Mean 
macular 
sensitivity  
pre 
Mean 
macular 
sensitivity 
post 
Mean 
macular 
defect 
pre 
Mean 
macular 
defect 
post 
Fixation 
spot pre 
Fixation spot 
post 
Number of eyes  14 14 14 14 14 14 
Mean 11.43 14.32 -4.20 -2.70 65.06% 66.78% 
Standard 
deviation 
±3.151 ±3.167 ±2.230 ±1.230 ±23.411 ±24.813 
Minimum 5 8 -14 -11 20% 17% 
Maximum 17 19 -2 0 99% 97% 
P value 0.0228* 0.0366* 0.851 
* Statistically significant  
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Table 5: Microperimetry relations between pre- and postoperative macular sensitivity, 
macular defect and fixation spot in eyes that underwent peeling with BBG assisted 
staining. 
 Number of 
patients  
A 
B 
C 
Total 
2
  
12
 
0
 
 
14 
D 
E 
F 
Total 
2
 
 
12 
0
  
14 
G 
H 
I 
Total 
7
 
 
7
 
 
0
 
 
14 
A. Mean macular sensitivity postoperative <Mean macular sensitivity preoperative. 
B. Mean macular sensitivity postoperative >Mean macular sensitivity preoperative. 
C. Mean macular sensitivity postoperative =Mean macular sensitivity preoperative. 
D. Mean macular defect postoperative >Mean macular defect preoperative. 
E. Mean macular defect postoperative <Mean macular defect preoperative. 
F. Mean macular defect postoperative =Mean macular defect preoperative. 
G. Fixation spot postoperative < Fixation spot preoperative. 
H. Fixation spot postoperative > Fixation spot preoperative. 
I. Fixation spot postoperative = Fixation spot preoperative. 
 
 
 
 
 
 
 
 
 
 
Mean macular 
sensitivity (post –pre) 
Mean macular 
defect (post –pre) 
Fixation spot (post –pre) 
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3.1.2- Eyes that underwent ILM peeling without assisted staining (A2). 
Two eyes that underwent peeling of ILM without assisted BBG staining, the mean 
visual acuity, improved from 0.15 preoperative to 0.8 postoperative. 
Using microperimetry, the mean macular sensitivity of eyes that underwent peeling 
without assisted BBG staining improved from 16.00 dB preoperative to 18.00 dB 
postoperative. The mean macular defect was -3.5 dB preoperative and improved to -1.5 dB 
postoperative. The mean fixation spot was 53% preoperative improved to 74% postoperative 
(Table 6). 
 
Table 6: Microperimetry relations between the mean preoperative versus postoperative 
macular sensitivity, mean macular defect and fixation spot in eyes that underwent 
peeling without assisted BBG staining. 
 Macular 
sensitivity  
pre- 
Macular 
sensitivity 
post- 
Macular 
defect pre- 
Macular 
defect 
post- 
Fixation 
spot pre- 
Fixation 
spot 
post- 
Number of eyes    2 2 2 2 2 2 
Minimum 14 17 -5 -3 45% 69% 
Mean 16.00 18.00 -3.5 -1.5 53% 74% 
Maximum 18 19 -2 0 61% 79% 
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3.1.3-Results of spectralis OCT measurements in eyes that underwent ILM 
peeling with and without assisted BBG staining.  
Measurements of the central macular thickness by spectralis OCT, revealed a mean 
central thickness of 240.42 µm postoperative. No preoperative data could be obtained 
because of the underlying process of macular hole (Table 7). 
Table 7. Postoperative OCT macular thickness, using Heidelberg spectralis OCT, with 
and without BBG assisted staining. 
 OCT postoperative  µm 
Mean 
Standard deviation 
Minimum 
Maximum 
240.42 
± 32.563 
190 
298 
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Case I.  Idiopathic macular hole  
 
 
 
 
 
 
 
  
 
 
Fig 3-1: Preoperative colored fundus photo 
of an eye with macular hole stage 3.  
Fig 3-2: Postoperative colored fundus 
photo of the same eye after hole closure. 
 
Fig 3-3: Preoperative Spectralis OCT of the macula of the same eye with 
idiopathic macular hole stage 3. 
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Fig 3-4: Postoperative Spectralis OCT of the macula of the same eye with macular hole 
closure. 
 
Fig 3-5: Preoperative fundus 
fluorescein angiography of the same 
eye with macular hole showing window 
defect (hyperfluorescence). 
Fig 3-6: Postoperative fundus fluorescein 
angiography of the same eye with macular 
hole closure (no defect). 
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Fig 3-7: Preoperative fundus 
microperimetry (numerical) of the same 
eye with macular hole showing central 
scotoma. 
Fig 3-8: Postoperative fundus 
microperimetry (numerical) of the same eye 
with macular hole showing no scotoma. 
Fig 3-9: Preoperative fundus 
microperimetry (map) and fixation 
spot of the same eye with macular 
hole showing central scotoma and 
eccentric fixation. 
Fig 3-10: Postoperative fundus microperimetry 
(map) and fixation spot of the same eye after 
closure of macular hole showing no scotoma 
and central fixation. 
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3.2- Primary macular pucker and vitreomacular traction 
syndrome (group B)  
 
Cases with macular pucker and vitreomacular traction syndrome were studied 
together as one group because of similarity of their pathogenesis. 
Twenty-four eyes with macular pucker and vitreomacular traction were studied, 17 eyes 
underwent suturless pars plana vitrectomy and peeling of ILM using (BBG) assisted staining and 
7 eyes without assisted staining (table 8).  
 
Table 8: ILM peeling of eyes with macular pucker and vitreomacular traction 
syndrome. 
Number of eyes Frequency Percent 
Without stain 
With ( BBG) stain 
Total number 
7 
17 
24 
29.2% 
70.8% 
100% 
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3.2.1- Eyes that underwent ILM peeling with assisted BBG staining (B1). 
       Measurements of the mean visual acuity in eyes that underwent peeling of ILM with 
assisted BBG staining tested by decimal chart revealed postoperative improvement of 
two or more lines in 14 eyes, deteriorated in 2 eyes and were equal in 1 eye. This 
improvement was statistically significant (p=0.02) (Table 9). 
 
Table 9. Comparison between mean preoperative versus post operative visual acuity, in 
eyes that underwent peeling of ILM with assisted BBG staining.  
 
Number of eyes Mean visual acuity 
preoperative   
Mean visual acuity 
postoperative  
P value 
 
17 0.35 0.65 0.02* 
 * Statistically significant  
 
 
Using spectralis  OCT in patients with macular pucker and vitreomacular traction, 
measuring the central macular thickness of eyes that underwent peeling of ILM with 
assisted BBG staining revealed non significant  postoperative improvement with decrease 
of the mean central macular thickness from 432.05 µm preoperative to 402 µm 
postoperative (Table10). 
 
Table 10. OCT measurements of central macular thickness preoperative and 
postoperative in eyes that underwent peeling of ILM with assisted BBG staining. 
  
Mean µm 
 
Standard deviation 
 
Minimum 
 
Maximum 
OCT pre 432.05 ±122 315 740 
OCT post 402 ±98.510 220 658 
P value 0.435 
 
 
 
 
Using microperimetry in eyes with macular pucker and vitreomacular traction that 
underwent peeling of ILM with BBG assisted staining revealed improvement of the mean 
macular sensitivity from 13.95 dB preoperative to 16.30 dB postoperative (improvement 
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in 14 eyes out of 17). This improvement was statistically significant (p=0.0062) 
(Table11, 12)  
The mean macular defect also improved from -5.72 dB preoperative to -2.88 dB 
postoperative (improvement in 14 eyes out of 17). This improvement was statistically 
significant as well (p=0.0367) (Table 11, 12). 
Measurements of the mean fixation spot revealed change from 66.32% preoperative 
to 71.02% postoperative (improvement of 11 eyes out of 17, worsened in 4 eyes and 
equal in two eyes). However, this change was statistically not significant (p=0.6168) 
(Table 11, 12). 
 
Table 11. Microperimetry relations between the mean preoperative and 
postoperative macular sensitivity, mean macular defect and fixation spot in eyes 
that underwent peeling of ILM with assisted BBG staining. 
 Mean 
macular 
sensitivity  
pre- 
Mean 
macular 
sensitivity 
post- 
Mean 
macular 
defect pre- 
Mean 
macular 
defect post- 
Fixation 
spot pre- 
Fixation 
spot post- 
Number of eyes  17 17 17 17 17 17 
Mean 13.95 16.30 -5.72 -2.88 66.32% 71.02% 
Standard deviation ± 2.112 ± 2.540 ± 3.743 ± 3.851 ± 26.350 ± 27.856 
Minimum 4 8 -12 -10 24% 9% 
Maximum 17 18 -4 -1 100% 100% 
P value 0.0062* 0.0367* 0.6168 
* Statistically significant  
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Table 12. Microperimetry relations between pre- and postoperative macular 
sensitivity, macular defect and fixation spot in eyes that underwent peeling of ILM 
with BBG assisted staining. 
 Number  of 
patients 
A 
B 
C 
Total 
2
  
14
  
1
 
 
17 
D 
E 
F 
Total 
2
 
 
14
 
 
1
  
17 
G 
H 
I 
Total 
4
 
 
11
 
 
2
 
 
17 
A. Mean macular sensitivity postoperative <Mean macular sensitivity preoperative. 
B. Mean macular sensitivity postoperative >Mean macular sensitivity preoperative.  
C. Mean macular sensitivity postoperative =Mean macular sensitivity preoperative. 
D. Mean macular defect postoperative >Mean macular defect preoperative. 
E. Mean macular defect postoperative <Mean macular defect preoperative. 
F. Mean macular defect postoperative =Mean macular defect preoperative. 
G. Fixation spot postoperative < Fixation spot preoperative. 
H. Fixation spot postoperative > Fixation spot preoperative. 
I. Fixation spot postoperative = Fixation spot preoperative. 
 
 
 
 
 
 
 
 
 
 
 
 
Mean macular 
sensitivity (post –pre) 
Mean macular 
defect (post –pre) 
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3.2.2- Eyes that underwent ILM peeling without assisted staining (B2). 
Measurements of the mean visual acuity of 7 eyes that underwent peeling of ILM 
without assisted staining tested by decimal chart, revealed postoperative improvement of 
one or more lines in 6 eyes and deteriorated in one eye. This improvement was 
statistically not significant (p=0.97) (Table 13). 
 
 
 
Table 13. Comparison between mean preoperative and postoperative visual acuity in 
eyes with macular pucker and vitreomacular traction that underwent peeling of ILM 
without assisted staining.  
 
Number of eyes Mean visual acuity 
preoperative 
Mean visual acuity 
postoperative 
P value 
7 0.40 0.50 0.97 
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Using microperimetry in eyes with macular pucker and vitreomacular traction that 
underwent peeling of ILM without assisted staining revealed improvement of the mean 
macular sensitivity from 14.52 dB preoperative to 16.6 dB postoperative (improved in 6 
eyes out of 7). However, this improvement was not statistically significant (p=0.0928) 
(Table 14, 15)  
The mean macular defect also improved from -4.35 dB preoperative to -3.42 dB 
postoperative (improvement in 6 eyes out of 7). This improvement was statistically not 
significant as well (p=0.4609) (Table 14, 15)  
Measurements of the mean fixation spot revealed change from 58.94 % preoperative 
to 72.71% postoperative with improvement of 4 eyes out of 7 and worsened in 3 eyes. 
This change was statistically not significant (p=0.2996) (Table 14, 15). 
 
Table 14. Microperimetry relations between the mean preoperative versus 
postoperative macular sensitivity, mean macular defect and fixation spot in eyes that 
underwent peeling without assisted BBG staining.  
 Mean 
macular 
sensitivity  
pre 
Mean 
macular 
sensitivity 
post 
Mean 
macular 
defect pre 
Mean 
macular 
defect 
post 
Fixation 
spot pre 
Fixation 
spot post 
Number of eyes  7 7 7 7 7 7 
Mean 14.52 16.6 -4.35 -3.42 58.94% 72.71% 
Standard deviation ± 2.54 ± 1.621 ± 2.854 ± 1.513 ± 25.02 ± 22.43 
Minimum 10 15 -9 -5 22% 39% 
Maximum 17 19 -2 -1 92% 98% 
P value 0.0928 0.4609 0.2996 
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Table 15. Microperimetry relations between the mean preoperative versus 
postoperative macular sensitivity, mean macular defect and fixation spot in eyes 
that underwent ILM peeling without assisted BBG staining. 
 Number  of 
patients 
A 
B 
C 
Total 
1
  
6
  
0
 
 
7 
D 
E 
F 
Total 
1 
6 
0
  
7 
G 
H 
I 
Total 
3
 
 
4
 
 
0
 
 
7 
 
A. Mean macular sensitivity postoperative <Mean macular sensitivity preoperative. 
B. Mean macular sensitivity postoperative >Mean macular sensitivity preoperative.  
C. Mean macular sensitivity postoperative =Mean macular sensitivity preoperative. 
D. Mean macular defect postoperative >Mean macular defect preoperative. 
E. Mean macular defect postoperative <Mean macular defect preoperative. 
F. Mean macular defect postoperative =Mean macular defect preoperative. 
G. Fixation spot postoperative < Fixation spot preoperative. 
H. Fixation spot postoperative > Fixation spot preoperative. 
I. Fixation spot postoperative = Fixation spot preoperative. 
 
 
 
 
 
 
 
 
 
 
 
Mean macular 
sensitivity (post –pre) 
Mean macular 
defect (post –pre) 
Fixation spot (post –pre) 
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       Using spectralis OCT in eyes with macular pucker and vitreomacular traction, 
that underwent peeling of ILM without assisted staining revealed non significant  
postoperative improvement, showing reduction of the mean central macular thickness 
from 414µm preoperative to 370 µm postoperative (Table 16) . 
 
Table 16: OCT measurements of central macular thickness preoperative and 
postoperative, using Heidelberg spectralis OCT, in eyes that underwent ILM 
peeling without assisted staining. 
  
Mean µm 
Standard deviation   
Minimum  
 
Maximum  
OCT pre 414 ± 168.210 309 684 
OCT post 370 ±  140.23 303 650 
P value 0.6047 
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Case 2 Macular pucker  
     
 
 
 
 
 
 
 
        
 
 
 
 
 
Fig 3-11: Preoperative colored 
fundus photo of an eye with 
macular pucker, showing 
epimacular membrane. 
Fig 3-12: Colored fundus photo of the 
same eye showing postoperative 
disappearance of epimacular 
membrane. 
Fig 3-13: Preoperative fundus 
autofluorescence of the same eye with 
macular pucker showing epimacular 
membrane and distortion of blood 
vessels. 
Fig 3-14: Fundus autofluorescence of the 
same eye in postoperative follow up 
showing disappearance of epimacular 
membrane without distortion of blood 
vessels.  
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Fig 3-15: Preoperative Spectralis OCT of the macula with macular pucker 
showing a wrinkled macular surface with an epimacular membrane. 
Fig 3-16: Postoperative Spectralis OCT of the same macula (no epimacular 
membrane visible). 
Fig 3-17: Preoperative three dimensions Spectralis OCT of the macula with macular 
pucker showing wrinkled macular surface and epimacular membrane.  
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Fig 3-18: Postoperative three dimensions Spectralis OCT of the same macula with 
macular pucker showing smooth macular surface and disappearance of wrinkles. 
Fig 3-19: Preoperative fundus 
microperimetry (map) and fixation spot of 
the same eye with macular Pucker showing 
decreased sensitivity. 
Fig 3-20: Postoperative fundus 
microperimetry (map) and fixation spot 
of the same eye with increased 
sensitivity. 
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Case 3 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig 3-21: Preoperative fundus 
fluorescein angiography of an eye with 
macular pucker showing distortion of 
retinal vessels and mild cystoid edema. 
Fig 3-22: Postoperative fundus 
fluorescein angiography of the same 
eye with macular pucker showing no 
distortion of blood vessels and no 
edema. 
Fig 3-23: Preoperative Spectralis OCT of the macula with macular pucker showing 
irregular macular surface with wrinkled epimacular membrane. 
  
51 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3-24: Postoperative Spectralis OCT of the same macula with macular pucker 
showing decreased macular thickness. 
 
Fig 3-25: Preoperative fundus 
microperimetry (map) and fixation 
spot of the same eye with macular 
Pucker showing decreased sensitivity 
in the upper part of the macula. 
Fig 3-26: Postoperative fundus 
microperimetry (map) and fixation spot 
of the same eye with increased 
sensitivity. 
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Case 4 Vitreomacular traction  
 
   
 
 
  
 
   
 
 
 
 
Fig 3-27: Preoperative colored fundus 
photo of an eye with vitreomacular 
traction showing tractional 
membrane. 
Fig 3-28: Postoperative colored 
fundus photo of the same eye with 
vitreomacular traction showing no 
membrane. 
Fig 3-29: Preoperative fundus 
microperimetry (map) of the same eye 
with vitreomacular traction showing 
marked decrease of macular sensitivity. 
Fig 3-30: Postoperative fundus 
microperimetry (map) of the same eye with 
vitreomacular traction showing 
improvement of macular sensitivity  
  
53 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3-31: Preoperative fundus 
fluorescein angiography of the 
same eye with vitreomacular 
traction showing moderate 
cystoid macular edema. 
Fig 3-32: Postoperative fundus 
fluorescein angiography of the same 
eye with vitreomacular traction 
showing mild cystoid macular edema. 
Fig 3-33: Preoperative three dimensions Spectralis OCT of the macula with 
vitreomacular traction showing marked irregularities of the macular surface with 
epiretinal membrane.  
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Fig 3-34: Postoperative three dimensions Spectralis OCT of the same macula 
with vitreomacular traction showing improvement of the surface irregularities.  
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4. DISCUSSIO? 
Vitreous surgery with epiretinal membrane peeling and removal of the ILM can 
successfully treat macular hole, vitreomacular traction and macular pucker. However, 
difficulties in visualization of the virtually translucent ILM can present technical 
challenges. It is widely recognized that without surgical adjuvants it may be extremely 
difficult to remove the membranes due to poor visibility of the ILM and epiretinal 
membranes. Staining of the ILM is therefore one of the major developments in surgery 
for such vitreoretinal diseases. 
[83-84]
   
Brooks (2000) reported that ILM peeling seemed to be especially beneficial in eyes 
with primary surgical failure or reopened, large or chronic holes and reported that an 
effect of ILM peeling was most obvious in eyes after primary surgical failure and for 
holes with longer duration or large size. 
[46]
 
Several vitreoretinal publications have discussed the functional and anatomical 
outcome of using various types of assisted staining of ILM peeling in macular surgery. 
None of these researches have evaluated the precise postoperative effects of the new stain 
BBG on macular functions evaluated by microperimetry in macular hole, macular pucker 
and vitreomacular traction. 
 Interpretation of our results was therefore matched with other studies using other 
stains and different surgical techniques.  
With microperimetry, it is possible to achieve a complete mapping of central retinal 
sensitivity and an analysis of fixation behavior. In addition, it is possible to detect 
macular damage in macular holes and pucker.
 [85-86]
  
In the current study, forty cases were enrolled in a prospective observational study 
with a mean follow up period of 93.875 days. Cases were classified into 2 major groups; 
group A included 16 eyes with idiopathic macular hole and group B included 24 eyes 
with macular pucker and vitreomacular traction syndrome. 
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Group A (cases with idiopathic macular hole) was further subdivided into 2 
subgroups; group A1 included 14 eyes that underwent ILM peeling with assisted BBG 
staining following pars plana vitrectomy and group A2 included 2 eyes that underwent 
ILM peeling without assisted staining following pars plana vitrectomy. 
Measuring visual acuity in eyes with idiopathic macular hole that underwent peeling 
of ILM with BBG staining, revealed improvement in postoperative follow up compared 
to preoperative visual acuity (improvement in 13 out of 14 eyes). A statistically 
significant postoperative improvement of mean macular sensitivity and mean macular 
defect in 12 out of 14 eyes (measured by microperimetry) was detected, while the change 
of postoperative fixation spot to preoperative was statistically not significant.  
Eyes that underwent peeling of ILM without assisted BBG staining revealed slight 
improvement of the mean visual acuity, mean macular sensitivity and mean fixation spot, 
however, statistical correlation or any other conclusions could not be assessed due to the 
low number of this subgroup.  
Kumagai et al., (2004) reported that the closure rate of holes larger than 400 µm was 
significantly lower than in holes smaller than 400 µm with or without ILM peeling. The 
closure rate of holes older than 6 months was significantly lower than in holes younger 
than 6 months. Preoperative visual acuity of the ILM–peeled group with assisted ICG 
was better than the non-ILM peeled group. Moreover, visual acuity improvement in the 
non-ILM peeled group tended to be better than in the ILM–peeled group. This result may 
be related to ICG use. 
[87]
  
Christensen (2009) examined the value of ILM peeling in macular hole. His results 
showed that surgery with ILM peeling is associated with a significantly higher closure 
rate than surgery without ILM peeling, 95% and 45% respectively. The author concluded 
that the visual outcomes were not significantly different between eyes without ILM 
peeling, peeling with ICG and peeling with trypan blue. 
[88]  
Lee et al., (2005) studied two groups of patients with idiopathic macular hole. They 
studied 14 patients that underwent ILM peeling with assisted ICG stain and 16 patients 
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underwent ILM peeling with trypan blue assisted staining. There was a significant 
difference in the postoperative visual acuities in the trypan blue group with better visual 
acuities than in the indocyanine green group. Hole closure was successful in 91.9% of all 
patients. 
[89]
  
Tognetto et al., (2006) studied patients suffering from macular hole, treated with 
and without ICG assisted ILM peeling. Anatomic success was more frequent when ICG 
was not used. In addition patients who achieved hole closure after ILM peeling, the 
functional results were better when ICG was not used. 
[90]  
Our results were similar in some aspects to Ferencz et al., (2006) who studied two 
groups of patients with idiopathic macular hole, group A consisted of 21 eyes that 
underwent peeling with indocyanin green (ICG) assisted staining, group B consisted of 9 
eyes that underwent ILM peeling without assisted staining. Visual acuity improved in 
both groups. There was no statistically significant difference between groups A and B at 
three and six months after surgery, after 12 months in group B there was a significant 
improvement in visual acuity compared to baseline. At 20 months follow up examination 
a significant improvement in both groups compared with the preoperative results was 
observed, and visual acuity was significantly better in group B than group A.
 [91]
  
Figueroa et al., (2008) studied patients with macular hole, the first group of  9  
patients were subjected to ILM peeling with trypan blue 0.06 % assisted staining and 
second group of 9 patients trypan blue 0.15%  assisted staining was used. There was no 
statistically significant difference between postoperative visual acuities of the two groups 
when different concentrations of trypan blue dye were used. Also in ERG examination, 
no significant difference was found between the eyes with macular hole and the 
contralateral eyes before and after surgery. The closure rate was 88.9% for group 1 and 
100% of group 2. 
[92]
   
In our study, group B (macular pucker and vitreomacular traction syndrome cases) 
was further subdivided into 2 subgroups; group B1 consisted of 17 eyes that underwent 
ILM peeling with assisted BBG staining following pars plana vitrectomy and group B2 
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consisted of 7 eyes that underwent ILM peeling without assisted staining following pars 
plana vitrectomy. Visual acuity of eyes with assisted staining revealed, significant 
postoperative improvement compared to preoperative visual acuity. 
The central macular thickness of our macular pucker and vitreomacular traction 
syndrome cases, measured by spectralis OCT, showed obvious postoperative  
improvement with decrease in mean macular thickness, after vitrectomy and ILM peeling 
whether with or without staining.  
Using microperimetry, the correct diagnosis of macular holes versus pseudo-holes 
or epiretinal membranes, which may be difficult to differentiate in early stages, is 
simplified by identification of the amount of functional impairment. Eyes suffering from 
macular holes develop an absolute scotoma. Consecutively, a movement of fixation 
outside the pathologic area mostly towards the left margin at the retina i.e. temporal in 
right eyes. Stability of fixation showed no significant correlation to visual acuity
. [93-94]  
Using microperimetry in the current study, cases with macular pucker and 
vitreomacular traction that underwent peeling of ILM with BBG assisted staining 
revealed significant postoperative improvement of mean macular sensitivity and mean 
macular defect in 14 out of 17 eyes, while the postoperative change in the fixation spot 
was statistically not significant. 
Measurement of postoperative visual acuity of eyes that underwent peeling of ILM 
without assisted staining revealed non-significant improvement compared to the 
preoperative acuity. Similarly, a statistically non-significant improvement of mean 
macular sensitivity, macular defect and fixation spot was detected in these cases.  
Park et al., (2003) studied 44 patients with macular pucker divided into 2 groups. 
Group 1, consisted of 24 patients with macular pucker that underwent pars plana 
vitrectomy and ILM peeling without assisted staining. Group 2, consisted of 20 patients 
that underwent pars plana vitrectomy and removal of epimacular membrane without ILM 
peeling. Visual acuity improved or was unchanged in 19 of 24 eyes without ILM peeling 
and in all eyes with ILM peeling. At the final visit 21% of eyes without ILM peeling 
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showed evidence of recurrent macular pucker or persistent contraction of the ILM and the 
retinal vessels. None of the eyes with ILM peeling had evidence of a recurrent macular 
pucker. 
[45]  
Larsson Jörgen (2004) studied 11 patients with vitreomacular traction syndrome that 
underwent pars plana vitrectomy with posterior hyaloid removal but without ILM 
peeling. The mean retinal thickness was 608 µm ± 260 µm and improved to 243 µm± 66 
µm after 6 months follow up. This difference was statistically significant. 
[95] 
Chung et al., (2008) studied 6 eyes with vitreomacular traction syndrome that 
underwent pars plana vitrectomy and peeling of posterior hyaloid without ILM peeling. 
The visual acuity significantly improved from 0.4 to 0.75, the mean preoperative foveal 
thickness was 406 µm, significantly improved and decreased to 241 µm 3 months after 
surgery. 
 [96]  
On the contrary of our results, Gandorfer et al., (2003) studied 14 patients with 
epiretinal membranes that underwent peeling of ILM in 5 eyes with assisted ICG peeling 
and 9 eyes without assisted staining. Preoperative visual acuity ranged from 20/400 - 
20/30 equivalent to 0.05 - 0.67 decimal. Final postoperative visual acuity ranged from 
20/400-20/20 equivalent to 0.05 - 1 decimal. The postoperative visual acuity improved in 
8 eyes, stable in 5 eyes and deteriorated in one eye. In five out of six eyes without 
postoperative visual improvement, indocyanine green was used to stain ILM. 
[66] 
Li et al., (2003) examined 14 patients with epiretinal membranes that underwent 
pars plana vitrectomy with internal limiting membrane assisted trypan blue 0.06% 
peeling. The mean age was 60.7 years with preoperative visual acuity of 1/60 to 6/6 
Snellen chart, equivalent to 0.02 1.0 decimal. Postoperative visual acuity improved and 
ranged from 5/60 to 6/6 Snellen chart, equivalent to 0.083 to 1 decimal, with a mean 
follow  up  period of 4.4 months. Vision improved or  maintained in all  patients. 
[55]  
Haritoglou et al., (2004) studied patients with macular pucker. The first group of 10 
patients were subjected to ILM peeling with trypan blue assisted staining and the second 
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group of 10 patients that underwent ILM peeling, no assisted staining was used. A 
deterioration of visual acuity was seen only in group 2 (without trypan blue) in 3 of 10 
patients. 
[44]
  
Our results were similar to Enaida et al., (2006) who examined 10 patients with 
macular hole and 10 patients with macular pucker. All cases underwent ILM peeling, 
using BBG assisted staining. Macular holes were closed anatomically in all cases with 
postoperative improvement in visual acuity. In macular pucker eyes, the mean central 
foveal thickness also improved and decreased from 454.7µm preoperative to 249.4 µm 
postoperative, the mean visual acuity improved postoperatively as well. 
[97]  
Richter-Mueksch et al., (2007) studied 19 patients with idiopathic macular hole and 
18 patients with macular pucker that underwent ICG assisted ILM peeling. 
Microperimetry was done to all cases before surgery and 3 months after surgery. In eyes 
with macular hole, the mean preoperative macular sensitivity done by microperimetry 
was 11.3 dB improved to 12.8 dB after 3 months, in eyes with macular pucker the mean 
preoperative sensitivity was 10.7 dB and improved to 12.7 dB. This increase was 
statistically significant. Stability of fixation improved and increased significantly in both 
groups. 
[86]  
Cappello et al., (2009) studied 18 patients with idiopathic macular hole and 41 eyes 
with macular pucker that underwent ILM peeling with ICG assisted staining, trypan blue 
assisted staining and without staining. The mean preoperative macular sensitivity 
(measured by microperimetry) in eyes with macular hole was 10.2dB improved to 12.9 
dB at 3 months post operative, 15.0 dB at 6 months and 14.1 dB at 12 months 
postoperative. In patients with macular pucker the mean preoperative macular sensitivity 
was 13.7dB and improved to 14.8 dB after 3 months postoperative, 15.1 dB at 6 months 
postoperative and 15.0 dB at 12 months postoperative. There was no statistical difference 
in macular sensitivity between eyes using ICG, Trypan blue or without staining that 
underwent ILM peeling. 
[98]  
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Our results were similar in some aspects to Henrich et al., (2009) who studied 17 
patients with macular holes, epiretinal membranes, vitreoretinal traction syndromes and 
cystoid macular edema. All were subjected to peeling of ILM with BBG assisted staining 
and follow up period of 3 months. The visual acuity increased from 0.25 preoperatively 
to 0.4 postoperatively. Central retinal OCT thickness showed postoperative improvement 
with reduction, with range from +7 to -295 µm. 
[99] 
 
Schumann et al., (2009) examined the retinal cleavage plane of the internal limiting 
membrane (ILM) removed during macular surgery. In cases that underwent ILM peeling 
with ICG assisted staining and without staining, a serious amount of inner retinal 
elements adherent to the retinal side of ILM was detected. It remains uncertain if the 
presence of retinal cell fragments at the ILM correlates with functional deficit. In 
contrast, ILM specimens with brilliant blue G staining and trypan blue showed 
significantly less retinal fragments at the ILM. 
[100]  
In conclusion, we clearly demonstrated that assisted BBG staining of ILM during 
vitrectomy of eyes suffering from macular hole, macular pucker and vitreomacular 
traction proved safety of the stain on retinal tissue with postoperative improvement of the 
acuity of vision, macular thickness, macular sensitivity, macular defect, fixation spot and 
successful closure of macular hole. 
Our results imply that, microperimetry is a safe, non-invasive and accurate 
documentary investigation that should be done to all macular disease patients especially 
those undergoing macular surgery pre and postoperative. It can relate the degree of 
macular dysfunctions "even asymptomatic lesions" to specific anatomical locations.  
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       5. SUMMARY 
Purpose: To evaluate anatomical and functional outcome of internal limiting membrane 
(ILM) peeling with and without  BBG staining in cases of idiopathic macular hole, 
macular pucker and vitreomacular traction syndrome. 
Design: Prospective, observational and non randomized study. 
Patients and methods: Sixteen eyes suffered from idiopathic macular hole; fourteen 
eyes underwent pars plana vitrectomy with ILM peeling using BBG staining and two 
eyes without staining. 
     Twenty-four eyes suffered from macular pucker and vitreomacular traction syndrome; 
seventeen eyes underwent pars plana vitrectomy with ILM peeling using BBG staining 
and seven eyes without staining.  
    In all patients best corrected visual acuity using decimal chart, spectralis OCT and 
macular sensitivity (mean sensitivity, mean defect and fixation spot) using 
microperimetry were determined before surgery and 3 months after surgery.   
Results: All cases of macular hole achieved successful closure of the hole after surgery. 
Measurements of the visual acuity, macular sensitivity and macular defect of eyes with 
macular hole that underwent peeling of ILM with and without assisted staining, revealed 
a statistically significant postoperative improvement.  
      Eyes with macular pucker and vitreomacular traction that underwent peeling of ILM 
using BBG assisted staining achieved a significant postoperative improvement of visual 
acuity (p=0.02), while a non-significant postoperative improvement occurred in visual 
acuity of eyes that underwent peeling without assisted staining  (p=0.97).  
      Using microperimetry, a statistically significant improvement of the mean macular 
sensitivity and macular defect was observed in eyes that underwent peeling with assisted 
BBG staining (p=0.0062), (p=0. 0.0367) respectively and a non-significant improvement 
of eyes that underwent peeling without assisted staining (p=0.0928). 
Conclusions: Peeling of ILM is a surgical procedure that can be technically challenging 
unless a dye is used to stain the transparent ILM.  
     Assisted BBG staining of ILM during vitrectomy of eyes with macular hole, macular 
pucker and vitreomacular traction proved safety of the stain on retinal tissue with 
postoperative improvement of the visual acuity, macular thickness, macular sensitivity, 
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macular defect and fixation spot. Microperimetry is a safe, non-invasive and accurate 
documentary investigation that should be done to all macular disease patients especially 
those undergoing macular surgery. 
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6. Zusammenfassung 
Ziel: Die vorgelegte Arbeit untersucht die anatomischen und funktionellen Ergebnisse 
nach ILM Peeling, mit oder ohne den Einsatz unterstützender Farbstoffe für die 
Vitrektomie bei Patienten mit Makulaforamen, Macular pucker und Vitreomakuläres 
Traktionssyndrom (VMTS).  
Design: Prospektive, nicht randomisierte Beobachtungsstudie. 
Patienten und Methoden: Von sechzehn Patienten mit idiopathischem Makulaforamen, 
die mittels pars plana Vitrektomie (ppV) und ILM Peeling behandelt wurden erhielten 
vierzehn Augen während des Membran Peelings Brilliantblau als Vitalfarbstoff und zwei 
Augen keinen Vitalfarbstoff.  
Von vierundzwanzig Patienten mit Macular pucker und Vitreomakulärem 
Traktionssyndrom (VMTS), die mittel pars plana Vitrektomie (ppV) und ILM Peeling 
behandelt wurden erhielten siebzehn Augen während des Membran Peelings Brilliantblau 
als Vitalfarbstoff und sieben Augen kein Vitalfarbstoff.  
Bei allen Patienten wurden die zentrale Sehschärfe (Dezimal-Tafel), eine Spectraldomain 
OCT und eine Mikroperimetrie zur Beurteilung der Empfindlichkeit, der Defekttiefe der 
Makula und des Fixationspunktes durchgeführt. 
Alle Untersuchungen wurden vor und 3 Monate nach der Operation durchgeführt. 
Ergebnisse: In allen Fällen konnte durch die Operation ein Verschluss des 
Makulaforamens erzielt werden. 
Die Bestimmung der Sehschärfe, der Makula-Sensitivität, der zentralen Defekttiefe und 
des Fixationspunktes der Augen mit Makulaforamen, die einem ILM Peeling mit und 
ohne Farbstoff unterzogen wurden, ergab bei allen Augen eine postoperative 
Befundverbesserung. Diese Verbesserung war statistisch signifikant. 
     Bei den Augen mit Makular Pucker und VMTS, die einer Vitrektomie mit Brilliant 
Blau G (BBG) unterstütztem Membran Peeling der ILM unterzogen wurden, zeigte sich 
bei allen eine hoch signifikante postoperative Verbesserung der Sehschärfe (P=0.02), 
während bei den Augen, die einer Vitrektomie ohne Vitalfarbstoff unterstütztem 
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Membran Peeling der ILM unterzogen wurden nur eine nicht-signifikante postoperative 
Verbesserung der Sehschärfe nachgewiesen werden konnte ( p=0.97).  
      In der Mikroperimetrie konnte bei den Augen, die sich einem Membran Peeling mit 
BBG Unterstützung unterzogen, eine statistisch signifikante Verbesserung der mittleren 
Makula-Sensitivität (p=0.0062) und der Makula-Defekttiefe (p=0.0367)  gezeigt werden. 
Bei den Augen, die einem Peeling ohne Vitalfarbstoff-Unterstützung unterzogen wurden, 
konnte hingegen keine signifikante Verbesserung detektiert werden (p=0.0928). 
Schlussfolgerungen: Das Peeling der ILM ist ein chirurgisches Verfahren, das technisch 
anspruchsvoll ist, solange kein Farbstoff verwendet wird. 
   Die Anwendung von  BBG zur Färbung der ILM in Augen mit Makulaforamen, 
Macular Pucker und Vitreomakuläres Traktionssyndrom (VMTS)  erwies sich als sicher 
mit postoperativer Verbesserung der Sehschärfe, der Makula-Dicke, der Makula-
Sensitivität, der Makula- Defekttiefe und des Fixationspunktes. 
    Die Mikroperimetrie ist eine sichere, nicht invasive und exakte Dokumentations- 
untersuchung, der sich alle Patienten mit einer Makulapathologie und speziell vor 
Makulachirurgie unterziehen sollten. 
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